Center For Financial Planning, Inc. Crispr Therapeutics Ag Transaction History
Center For Financial Planning, Inc.
- $736 Million
- Q3 2024
A detailed history of Center For Financial Planning, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 10 shares of CRSP stock, worth $548. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 10
-0.0%
Holding current value
$548
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
503Shares Held
57MCall Options Held
1.7MPut Options Held
1.8M-
Capital International Investors Los Angeles, CA7.87MShares$431 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$411 Million3.35% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$163 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$163 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$152 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.28B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....